<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">INT RO DUCT IO N Diagnosis of diabetes mellitus has been based on fasting plasma glucose(FPG) value and glucose value C o m p a r is o n o f G lu c o s e T o le r a n c e C a t e g o r ie s in t h e Ko r e a n P o p u la t io n Ac c o r d in g t o W o r ld He a lt h O r g a n iz a t io n a n d A m e r ic a n D ia b e t e s As s o c ia t io n D ia g n o s t ic C r it e r ia</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>M.D</roleName><forename type="first">Kyong</forename><forename type="middle">Soo</forename><surname>Park</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">Seoul National University College of Medicine</orgName>
								<address>
									<addrLine>28 YunKun-Dong, Chongno-Ku</addrLine>
									<postCode>110-744</postCode>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">INT RO DUCT IO N Diagnosis of diabetes mellitus has been based on fasting plasma glucose(FPG) value and glucose value C o m p a r is o n o f G lu c o s e T o le r a n c e C a t e g o r ie s in t h e Ko r e a n P o p u la t io n Ac c o r d in g t o W o r ld He a lt h O r g a n iz a t io n a n d A m e r ic a n D ia b e t e s As s o c ia t io n D ia g n o s t ic C r it e r ia</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-14T00:31+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>De p a rt m e nt o f Int e rn a l M e d ic ine , S e o u l N at io n a l U n iv e rs ity Co lle g e o f M e d ic ine , S e o u l, Ko re a O bj e c t iv e s : T o co m p a re t he p re v a le nc e a nd m e t a b o lic p ro f ile s o f g luc o s e t o le ra nc e c at e g o rie s a cc o rd ing t o W o rld He a lt h O rg a n iz at io n (W HO) a nd 19 9 7 A m e rica n Dia b e t e s A s s o c iat io n (A DA) f as t ing c rit e ria f o r t he d iag no s is o f d ia b e t e s m e llit us a nd im p a ire d g luc o s e m e t a b o lis m in t he Ko re a n p o p u lat io n. M e t h o d s : 2 2 5 1 s u bj e ct s w it h o ut p re v io us h is t o ry o f d ia b e t e s , w ho p a rt ic ip at e d in t h e Y o n c ho n d ia b e t e s e p id e m io lo g y s u rv e y in 19 93 , w e re c las s if ie d ac co rd ing t o b o t h c rit e ria. T h e p re v a le nc e o f g luco s e t o le ra nc e cat e g o rie s a n d t h e ag re e m e nt a c ro s s a ll c at e g o rie s o f g lu co s e t o le ra nc e w e re c a lc u lat e d. M e t a b o lic c ha ract e ris t ic s o f d if f e re nt g lu co s e t o le ra nce cat e g o rie s w e re co m p a re d. Re s u lt s : T he p re v a le nc e o f d ia b e t e s a nd im p a ire d f a s t ing g luco s e (IFG) ac co rd ing t o A DA f a s t ing c rit e ria w a s s im ila r t o t ho s e o f d ia b e t e s a nd im p a ire d g luco s e t o le ra nc e (IGT) ac co rd ing t o W HO c rit e ria , re s p e ct iv e ly. Ho w e v e r, 3 5. 5 % o f t he s u bj e ct s w h o w e re d iag no s e d as d ia b e t e s by W HO c rit e ria w e re re c la s s if ie d a s e it he r IFG o r no rm a l f a s t ing g lu co s e (N FG) , a n d 3 8 .5 % o f d ia b e t ic p at ie nt s ac co rd ing t o A DA f as t ing c rit e ria w e re IGT o r no rm a l g luco s e t o le ra nc e (N GT) by W HO c rit e ria. O n ly 3 1.3 % o f IGT s u bj e ct s re m a ine d as IFG a n d 6 2. 1 % w e re re c las s if ie d a s N FG. S im ila rly , 6 9 .4 % o f IFG s u bj e ct s w e re N GT by W HO c rit e ria. T he ag re e m e nt b e tw e e n t h e tw o c rit e ria w as p o o r (= 0 .3 1). Dis co rd a nt d ia b e t e s g ro u p s ha d h ig he r W HR , sy s t o lic a nd d ia s t o lic b lo o d p re s s u re , c ho le s t e ro l a nd t rig ly c e rid e le v e ls t h a n co n co rd a nt no n-d ia b e t e s g ro up. N o n-d ia b e t e s (W HO)/ d ia b e t e s (A DA) g ro up ha d h ig h e r W HR t h a n d ia b e t e s (W HO)/ no n-d ia b e t e s (A DA) g ro u p. T h e re w e re no d if f e re nc e s in o t h e r m e t a b o lic c ha ra ct e ris t ic s b e tw e e n t he tw o d is c o rd a nt d ia b e t e s g ro u p s. IGT/ N FG a nd N GT/ IFG g ro up s ho w e d h ig he r B M I, W HR , s y s t o lic a nd d ia s t o lic b lo o d p re s s u re , c ho le s t e ro l a nd t rig ly ce rid e le v e ls t ha n N GT/ N FG g ro up. M e t a b o lic c ha ra ct e ris t ic s o f IGT/ N FG g ro up w e re no t d if f e re nt f ro m t ho s e o f N GT/ IFG g ro u p e x ce p t IGT/ N FG s u bj e ct s w e re o ld e r t h a n N GT/ IFG s u bj e ct s. Co nc lu s io n : T he ag re e m e nt b e tw e e n W HO a nd A DA f a s t ing c rit e ria w a s p o o r. A DA f a s t ing c rit e ria ca n d e t e ct ne w d ia b e t ic p at ie nt s a nd s u bj e ct s w it h im p a ire d g luc o s e m e t a b o lis m w h o a re no t c las s if ie d a s d ia b e t e s o r IGT by W HO c rit e ria. Ho w e v e r, a s u b s t a nt ia l n u m b e r o f s u bj e ct s , w ho m ay hav e inc re as e d c a rd io v a s c u la r ris k a nd/ o r inc re as e d ris k f o r t he d e v e lo p m e nt o f d ia b e t e s a nd it s c o m p lic at io n , w ill b e m is s e d w he n us ing A DA f as t ing c rit e ria. Ke y W o rd s : d iag n o s is , d ia b e t e s m e llit us , im p a ire d g luco s e t o le ra nc e , im p a ire d f as t ing g luc o s e , f a s t ing p la s m a g lu co s e</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>measured 2 h after a standard 75 g glucose load(2-h PG). <ref type="bibr">1 ,2 )</ref> The cutpoint of these criteria is based mainly on the prevalence of microvascular complications. However, FPG cutpoint of 140 mg/dL has been challenged s ince it defined a greater degree of hyperglycemia than did the cutpoint of 2-h PG(200 mg/dL). <ref type="bibr" target="#b2">3 )</ref> Recently, American Diabetes Association(ADA) has proposed a revised diagnostic criteria that lowers the FPG cutpoint to 126 mg/dL. <ref type="bibr" target="#b3">4 )</ref> By lowering FPG cutpoint, cutpoints for the FPG and 2-h PG are believed to diagnose similar conditions, and ADA recommends that the FPG test is greatly preferred in clinical settings because of ease of administration, convenience, acceptability to patients and lower cost.</p><p>It is well established that diabetes mellitus and impaired glucose tolerance by WHO criteria <ref type="bibr">(1985)</ref> are also associated with an increased risk of development of cardiovasular disease and form part of the metabolic syndrome. <ref type="bibr" target="#b4">5 )</ref> At present, it is not clear whether metabolic characteristics of glucose tolerance categories based on FPG criteria are in agreement with those of WHO criteria(1985) or not. Larsson et al. <ref type="bibr" target="#b5">6 )</ref> reported that the subjects with IGT and IFG are comparable in terms of body mass index, blood pressure and serum lipids in a group of middle-aged Caucasian women, while Gimeno et al. <ref type="bibr" target="#b6">7 )</ref> showed that subjects with discordant diagnoses, who had IGT or diabetes by WHO criteria but who were normal by ADA fasting criteria, exhibited a higher number of cardiovascular risk factors (higher blood pressure and triglyceride and low HDL cholesterol) than those who were discordant (IFG/diabetes) by ADA fasting criteria but normal by WHO criteria.</p><p>In this study, we applied the revised ADA fasting criteria to data collected from a previously published population-based survey for diabetes in Korean subjects <ref type="bibr">8 ,9 )</ref> and compared the prevalence and metabolic profile of glucose tolerance categories with those of WHO criteria.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>R ES EA RC H DES IG N A ND MET HO DS</head><p>The Yonchon Study is a population-based diabetes epidemiology survey in t h e Korean population. The study population and research design have been described in detail, previously. <ref type="bibr">8 ,9 )</ref> Subjects were classified according to both WHO criteria and 1997 ADA fasting criteria.</p><p>S ubjects who were already using oral hypoglycemic agents , insulin or diet for diabetes were excluded from all analyses.</p><p>Prevalence of glucose tolerance categories were calculated for both sets of diagnostic criteria and to examine the agreement between t he two criteria, all categories of glucose tolerance were calculated. <ref type="bibr" target="#b9">10 )</ref> Metabolic characteristics of different glucose tolerance categories were compared. Differences among these groups were tested with analysis of variance. Statistical analyses were done us ing the Statistical Packages for Social Science(SPSS) 8.0 for windows. P-values &lt; 0.05(two-tailed) were considered to be statistically s ignificant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>R ES ULT S 1. Preva le nce of glucose tolera nce categories</head><p>The overall prevalence of diabetes did not differ between t h e two criteria. Prevalence of diabetes according to WHO(1985) criteria was 5.15 % and that according to ADA(1997) fasting criteria was 5.42 %. However, only 64.7%(75 of 116 subjects) of those who were diagnosed as diabetes according to WHO criteria were diagnosed as diabetes by ADA fasting criteria. 19.0 % of diabetes according to WHO criteria were reclassified as impaired fasting glucose(IFG) and 16.4 % as normal fasting glucose(NFG). S imilarly, 38.5 % of diabetic patients according to ADA fasting criteria were IGT or normal glucose tolerance(NGT) by WHO criteria <ref type="table">(Table 1)</ref>. The agreement between the two criteria for the diagnosis of previously unknown diabetes was poor( = 0.31)</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Metabolic profiles of glucose tolerance categories</head><p>Concordant and discordant diabetes groups were older than concordant non-diabetes group. They showed higher WHR, systolic and diastolic blood press ure, cholesterol and triglyceride levels than concordant non-diabetes group <ref type="table">(Table 2)</ref>. When comparing metabolic characteristics among diabetes groups, concordant diabetes [diabetes (WHO) / diabetes (ADA)] group showed higher triglyceride and lower HDL levels than discordant diabetes groups. Non-diabetes (WHO)/ diabetes (ADA) group had higher WHR than diabetes (WHO)/non-diabetes(ADA) group. There were no differences in other metabolic profiles between t he two discordant diabetes groups. <ref type="table">Table 3</ref>. showed metabolic profiles of subjects with impaired glucose metabolism. Concordant and discordant impaired glucose metabolism groups were older and had higher BMI, WHR, systolic and diastolic blood pressure, cholesterol and triglyceride levels than NGT/NFG group. IGT/IFG s ubjects showed higher WHR and triglyceride levels than discordant impaired glucose metabolis m groups(IGT/NFG, NGT/IFG). Metabolic profiles of IGT/NFG group were not different from those of NGT/IFG group, except that IGT/NFG group was older than NGT/IFG group. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ta ble 2 . Co mpa ris o n of Metabo lic Profile Amo ng Diabe tic S ubg ro ups Acco rding to WHO(1985) a nd ADA(1997 ) Dia g nos tic Crite ria</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>D IS C US S IO N</head><p>The revised ADA diagnostic criteria are intended to reduce the discrepancy between FPG and 2-h PG cutpoint and to encourage the use of FPG rather than t h e oral glucose tolerance test to diagnose diabetes. In this study, the prevalence of diabetes using ADA fasting criteria was similar with that us ing WHO(1985) criteria. However, the agreement between WHO and ADA fasting criteria was not good. A third of the subjects who were diagnosed as diabetes according to WHO criteria were reclassified as either IFG or NFG by ADA fasting criteria. S imilarly 38.5 % of the s ubjects who were diagnosed as diabetes by ADA fasting criteria were not diagnosed as having diabetes according to WHO criteria. Our study also showed that about 2/3 of IGT subjects were reclassified as NFG, which is very similar to previous reports showing that 70-80 % of IGT subjects were reclassified as NFG. <ref type="bibr">10 , 1 1)</ref> Conversely, 2/3 of IFG s ubjects were NGT by WHO criteria. These results are consistent with the reports which showed only moderate to poor agreement between t he two criteria <ref type="bibr">13 , 14 )</ref> Poor agreement between t he two criteria raised the concern that a substantial number of glucose intolerant subjects, who have a increased risk of diabetic complications or increased risk of developing diabetes mellitus and cardiovascular disease, may be ignored when using ADA fasting criteria.</p><p>Our results showed that discordant diabetes groups had higher WHR, blood pressure, cholesterol and triglyceride than the concordant non-diabetes group. However, metabolic characteristics of diabetes (WHO)/non-diabetes(ADA) group was s imilar to those of non-diabetes(WHO)/diabetes(ADA) group. This implies that when we use ADA fasting criteria to diagnose diabetes, we will miss a similar number of s ubjects who may have increased risk for diabetic complications .</p><p>Subjects with IGT are known to have increased risk of developing diabetes and cardiovascular disorders. <ref type="bibr">15 , 16 )</ref> In our population, IGT/NFG subjects had increased cardiovascular risk compared to NGT/NFG s ubjects. Although they were older than NGT/IFG subjects, other metabolic profiles were s imilar to those of NGT/IFG subjects. Thus, t he discordant impaired glucose metabolism group may have a similar risk for the development of diabetes and cardiovascular disease. These results are similar to the observation in a group of middle-aged Caucasian women <ref type="bibr" target="#b5">6 )</ref> while Gimeno et al. <ref type="bibr" target="#b6">7)</ref> s howed that subjects with discordant diagnoses, who had IGT or diabetes by WHO criteria but who were normal by ADA fasting criteria, exhibited a higher number of cardiovascular risk factors than those who were discordant (IFG/diabetes) by ADA fasting criteria but normal by WHO criteria. These results suggest that s ubjects with IGT who are reclassified as NFG by ADA fasting criteria have no less risk for development of diabetes and cardiovascular disease than subjects with NGT/IFG.</p><p>In conclusion, ADA fasting criteria can detect a s imilar number of diabetic patients and impaired glucose metabolis m. It can pick up new subjects who are not classified as diabetes or impaired glucose tolerance by WHO criteria. However, a substantial number of subjects, who may have increased cardiovascular ris k and/or increased risk for the development of diabetes , will be missed when using only FPG cutpoint. Long term study will be needed to evaluate whether glucose tolerance categories classified by ADA fasting criteria will result in decreased morbidity and mortality, compared to those according to WHO criteria.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Ta ble 1. Ag re e me nt be twe e n WHO(1985 ) a nd ADA (1997 ) Diag nos tic Crite ria : the Yo nc ho n Study</head><label></label><figDesc>The prevalence of IFG was 15.1%, while the prevalence of IGT was 12.1%. Only 31.3 %(85 of 272 s ubjects) of IGT subjects remained as IFG and 62.1 %(169 of 272 subjects) were reclassified as NFG and 6.8 %(18 of 272 subjects) as diabetes. Only 24.3 % of IFG s ubjects were IGT by WHO criteria and 69.4 % were NGT by WHO criteria.</figDesc><table><row><cell></cell><cell></cell><cell cols="2">WHO(1985)</cell><cell></cell></row><row><cell></cell><cell>NGT</cell><cell>IGT</cell><cell cols="2">Diabetes Combine</cell></row><row><cell>AFG</cell><cell>1591</cell><cell>169</cell><cell>19</cell><cell>1779</cell></row><row><cell>IFG</cell><cell>243</cell><cell>85</cell><cell>22</cell><cell>350</cell></row><row><cell>Diabetes</cell><cell>29</cell><cell>18</cell><cell>75</cell><cell>122</cell></row><row><cell>Combined</cell><cell>1863</cell><cell>272</cell><cell>116</cell><cell>2251</cell></row><row><cell cols="5">NGT: normal glucose tolerance, IGT: impaired glucose</cell></row><row><cell cols="5">tolerance, NFG: normal fasting glucose, IFG: impaired</cell></row><row><cell>fasting glucose</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Ta ble 3 . Co mpa ris o n of Me ta bo lic Profile fo r Impa ire d Gluco s e Metabo lis m Acco rding to WHO (1985) a nd ADA(1997) Crite ria</head><label></label><figDesc></figDesc><table><row><cell></cell><cell cols="2">Non-DM/</cell><cell></cell><cell cols="2">DM(WHO)/</cell><cell></cell><cell cols="2">Non-DM(WHO)/</cell><cell>DM(WHO)/</cell></row><row><cell></cell><cell cols="2">Non-DM</cell><cell></cell><cell cols="3">Non-DM(ADA)</cell><cell cols="2">DM(ADA)</cell><cell>DM(ADA)</cell></row><row><cell>Age(years)</cell><cell>53</cell><cell>13</cell><cell></cell><cell>62</cell><cell>14 *</cell><cell></cell><cell>59</cell><cell>12 *</cell><cell>58</cell><cell>12 *</cell></row><row><cell>Sex(M:F)</cell><cell cols="2">898/ 1190</cell><cell></cell><cell>21/20</cell><cell></cell><cell></cell><cell cols="2">29/ 18</cell><cell>44/31</cell></row><row><cell>BMI(kg/m2)</cell><cell>23.9</cell><cell>3.3</cell><cell></cell><cell>24.8</cell><cell>3.8</cell><cell></cell><cell>23.7</cell><cell>3.3</cell><cell>25.3</cell><cell>3.9 *</cell></row><row><cell>WHR</cell><cell>0.86</cell><cell>0.06</cell><cell></cell><cell>0.90</cell><cell>0.05 *</cell><cell></cell><cell>0.94</cell><cell>0.17 *</cell><cell>0.91</cell><cell>0.09 *</cell></row><row><cell>systolic BP(mmHg)</cell><cell>125</cell><cell>21</cell><cell></cell><cell>139</cell><cell>27 *</cell><cell></cell><cell>133</cell><cell>22 *</cell><cell>136</cell><cell>19 *</cell></row><row><cell>diastolic BP(mmHg)</cell><cell>80</cell><cell>13</cell><cell></cell><cell>88</cell><cell>17 *</cell><cell></cell><cell>85</cell><cell>14 *</cell><cell>87</cell><cell>13 *</cell></row><row><cell>Cholesterol</cell><cell>4.03</cell><cell cols="2">0.80</cell><cell>4.42</cell><cell cols="2">0.88 *</cell><cell>4.40</cell><cell>1.03 *</cell><cell>4.34</cell><cell>1.11 *</cell></row><row><cell>Triglyceride</cell><cell>1.64</cell><cell cols="2">1.16</cell><cell>2.20</cell><cell cols="2">1.48 *</cell><cell>2.36</cell><cell>1.59 *</cell><cell>2.83</cell><cell>2.11 *</cell></row><row><cell>HDL</cell><cell>0.96</cell><cell cols="2">0.28</cell><cell>1.03</cell><cell cols="2">0.41</cell><cell>0.98</cell><cell>0.41</cell><cell>0.88</cell><cell>0.34</cell></row><row><cell cols="5">:mmol /L, BP:blood pressure, DM: diabetes mellitus</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="9">* :p &lt; 0.05 vs Non-DM/Non-DM, : p &lt; 0.05 vs Non-DM/DM, : p &lt; 0.05 vs DM/Non-DM</cell></row><row><cell></cell><cell cols="3">NGT/NFG</cell><cell cols="2">IGT/NFG</cell><cell></cell><cell cols="2">NGT/IFG</cell><cell>IGT/IFG</cell></row><row><cell>Age(years)</cell><cell></cell><cell>51</cell><cell>13</cell><cell cols="2">59</cell><cell>11 *</cell><cell>54</cell><cell>12 *</cell><cell>59</cell><cell>13 *</cell></row><row><cell>Sex(M:F)</cell><cell></cell><cell>655/936</cell><cell></cell><cell></cell><cell cols="2">62/ 107</cell><cell cols="2">128/ 115</cell><cell>50/35</cell></row><row><cell>BMI(kg/m2)</cell><cell cols="2">23.7</cell><cell>3.1</cell><cell cols="2">24.6</cell><cell>3.8 *</cell><cell>24.2</cell><cell>3.5 *</cell><cell>25.0</cell><cell>3.2 *</cell></row><row><cell>WHR</cell><cell cols="2">0.86</cell><cell>0.06</cell><cell cols="2">0.88</cell><cell>0.06 *</cell><cell>0.87</cell><cell>0.06 *</cell><cell>0.89</cell><cell>0.06 *</cell></row><row><cell>systolic BP(mmHg)</cell><cell></cell><cell>123</cell><cell>21</cell><cell cols="2">131</cell><cell>23 *</cell><cell>129</cell><cell>20 *</cell><cell>133</cell><cell>22 *</cell></row><row><cell>diastolic BP(mmHg)</cell><cell></cell><cell>79</cell><cell>13</cell><cell cols="2">85</cell><cell>15 *</cell><cell>84</cell><cell>12 *</cell><cell>86</cell><cell>14 *</cell></row><row><cell>Cholesterol</cell><cell></cell><cell>4.01</cell><cell>0.78</cell><cell cols="2">4.14</cell><cell>0.85</cell><cell>4.14</cell><cell>0.80 *</cell><cell>4.27</cell><cell>0.75 *</cell></row><row><cell>Triglyceride</cell><cell></cell><cell>1.56</cell><cell>1.04</cell><cell cols="2">1.83</cell><cell>1.10 *</cell><cell>1.83</cell><cell>1.46 *</cell><cell>2.26</cell><cell>1.91 *</cell></row><row><cell>HDL</cell><cell></cell><cell>0.96</cell><cell>0.28</cell><cell cols="2">0.96</cell><cell>0.34</cell><cell>0.96</cell><cell>0.31</cell><cell>0.91</cell><cell>0.31</cell></row><row><cell cols="10">:mmol /L, BP:blood pressure, NGT:normal glucose tolerance, IGT: impaired glucose tolerance, NFG: normal fasting</cell></row><row><cell cols="3">glucose, IFG: impaired fasting glucose</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="8">* :p &lt; 0.05 vs NGT/NFG, : p &lt; 0.05 vs NGT/IFG, : p &lt; 0.05 vs IGT/NFG</cell><cell></cell></row></table><note></note></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">World Health Organization: Diabetes Mellitus: Report of a WHO study group</title>
		<imprint>
			<date type="published" when="1985" />
			<pubPlace>Geneva, World Health Org</pubPlace>
		</imprint>
	</monogr>
	<note type="report_type">Tech Rep. Ser</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance</title>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1039" to="1057" />
			<date type="published" when="1979" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">I</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Hadden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Knowler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Bennett</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.36.4.523</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="523" to="534" />
			<date type="published" when="1987-04-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The Expert Committee on the Diagnos is and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnos is and Class ification of Diabetes Mellitus</title>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1183" to="1197" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The Clinical Implications of Impaired Glucose Tolerance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kgmm</forename><surname>Alberti</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1096-9136(199611)13:11&lt;927::aid-dia279&gt;3.3.co;2-5</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetic Medicine</title>
		<title level="j" type="abbrev">Diabet. Med.</title>
		<idno type="ISSN">0742-3071</idno>
		<idno type="ISSNe">1096-9136</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="927" to="937" />
			<date type="published" when="1996-11" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Berglund</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Lindgarde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Ahren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1124" to="1129" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">G</forename><surname>Gimeno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Franco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Iunes</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.21.11.1889</idno>
		<idno type="PMID">9802738</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1889" to="1892" />
			<date type="published" when="1998-11-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Prevalence of Diabetes and IGT in Yonchon County, South Korea</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C-S</forename><surname>Koh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Shin</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.18.4.545</idno>
		<idno type="PMID">7497867</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/0c13/68bbc89fd396d9bbc0687a2854a73b0dce00.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="545" to="548" />
			<date type="published" when="1995-04-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Risk Factors for the Development of NIDDM in Yonchon County, Korea</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C-S</forename><surname>Koh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">I</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">S</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Y</forename><surname>Paik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">G</forename><surname>Yang</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.20.12.1842</idno>
		<idno type="PMID">9405904</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1842" to="1846" />
			<date type="published" when="1997-12-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The measurement of observer agreement for categorical data</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J R</forename><surname>Landis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">G</forename><surname>Koch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrics</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="159" to="74" />
			<date type="published" when="1977" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">J</forename><surname>Gomez-Perez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Aguilar-Salinas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Lopez-Alvarenga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Perez-Jauregui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">E</forename><surname>Guillen-Pineda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Rull</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.21.11.1886</idno>
		<idno type="PMID">9802737</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1886" to="1888" />
			<date type="published" when="1998-11-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Comparison of Diabetes Diagnostic Categories in the U.S. Population According to 1997 American Diabetes Association and 1980-1985 World Health Organization Diagnostic Criteria</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">I</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">C</forename><surname>Eastman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Cowie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Flegal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Eberhardt</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.20.12.1859</idno>
		<idno type="PMID">9405907</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1859" to="1862" />
			<date type="published" when="1997-12-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The 1997 American Diabetes Association Criteria Versus the 1985 World Health Organization Criteria for the Diagnosis of Abnormal Glucose Tolerance: Poor agreement in the Hoorn Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">D</forename><surname>Vegt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J M</forename><forename type="middle">M</forename><surname>Dekker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">D A</forename><surname>Stehouwer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Nijpels</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Bouter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Heine</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.21.10.1686</idno>
		<idno type="PMID">9773731</idno>
		<ptr type="open-access" target="https://research.vu.nl/ws/files/2894796/263639.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1686" to="1690" />
			<date type="published" when="1998-10-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Unwin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">G M M</forename><surname>Alberti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Bhopal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Harland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>White</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1096-9136(199807)15:7&lt;554::aid-dia626&gt;3.0.co;2-e</idno>
		<idno type="PMID">9686694</idno>
		<idno type="ark">ark:/67375/WNG-9XL811XF-6</idno>
		<idno type="istexId">C96A1E2BA93B7159FF283057BC0BB25AB33938AB</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetic Medicine</title>
		<title level="j" type="abbrev">Diabet. Med.</title>
		<idno type="ISSN">0742-3071</idno>
		<idno type="ISSNe">1096-9136</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="554" to="557" />
			<date type="published" when="1998-07" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Johnh.</forename><surname>Fuller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martinj.</forename><surname>Shipley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Geoffrey</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">John</forename><surname>Jarrett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harry</forename><surname>Keen</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(80)92651-3</idno>
		<idno type="PII">S0140-6736(80)92651-3</idno>
		<idno type="ark">ark:/67375/6H6-TL4FZQB7-R</idno>
		<idno type="istexId">0FE83CC7F7F6E97D4CB547BC8412158BDFFEE4EC</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="issue">8183</biblScope>
			<biblScope unit="page" from="1373" to="1376" />
			<date type="published" when="1980-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The Natural History of Impaired Glucose Tolerance in the Pima Indians</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mohammed</forename><forename type="middle">F</forename><surname>Saad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">C</forename><surname>Knowler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">J</forename><surname>Pettitt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">G</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">M</forename><surname>Mott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">H</forename><surname>Bennett</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejm198812083192302</idno>
		<idno type="PMID">3054559</idno>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">319</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="1500" to="1506" />
			<date type="published" when="1988-12-08" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
